Update Venetoclax in CLL
Zanubrutinib
Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
UpToDate
NCCN Guidelines for Patients
Patient Power
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL